Advertisement
The United States' deal with Gilead Sciences to scoop up nearly all of the world's supply of the only drug licensed to treat COVID-19 has outraged health experts.

U.S. Grab of Only COVID-19 Treatment Outrages Health Experts

0
Behavior sets a dangerous precedent for attempts to share scarce treatments during the pandemic, experts warn
Young children experiencing an initial vaccine-proximate febrile seizure do not have increased risk of developmental or behavioral problems

Post-Vaxx Febrile Seizures Not Linked to Child Development Outcomes

0
Risk of developmental, behavioral problems not up in young children with febrile seizures after vaccination
Patients with Alzheimer disease have increased iron concentration in the deep gray matter and neocortical regions compared with healthy controls

Brain Iron Concentrations Increased in Alzheimer Disease

0
Increased iron concentration seen in deep gray matter, neocortical regions versus healthy controls
For patients with type 2 diabetes at low cardiovascular risk

Comparative Effectiveness of Treatments Explored in T2DM

0
Greatest drop in HbA1c for insulin, specific glucagon-like peptide-1 receptor agonist added to metformin
Fake or unapproved COVID-19 antibody tests are being sold by scammers

FBI Warns of Scammers Selling Fake COVID-19 Antibody Tests

0
Consumers can protect themselves by checking FDA website for a list of approved antibody tests, testing companies
Top U.S. infectious disease expert Anthony Fauci

U.S. Could See 100,000 New Cases of COVID-19 Each Day, Fauci Says

0
Fauci and other health officials also testified before U.S. Senate about the need to build up confidence in vaccination
The incidence of venous thromboembolism and major bleeding is high among patients with primary central nervous system lymphoma

Incidence of VTE, Major Bleeding High in Primary CNS Lymphoma

0
VTE risk up with chemotherapy, radiation therapy; major bleeding risk up with PE, proximal DVT
Gilead Sciences

COVID-19 Drug Remdesivir Could Cost Up to $3,120 Per Patient

0
In the U.S., government programs, additional Gilead assistance should mean all patients have access to the drug
There has been a dramatic decrease in pediatric asthma-related emergency department use during the COVID-19 pandemic compared to the four previous years

ED Visits for Childhood Asthma Down During Pandemic

0
Similar pattern observed for all levels of asthma triage acuity
Hospitalized patients with COVID-19 receiving colchicine have significantly improved time to clinical deterioration

Colchicine May Improve Time to Clinical Deterioration in COVID-19

0
Significant improvement seen in time to clinical deterioration for hospitalized patients with COVID-19